Bitcoin Cash (BCH) Up $4.34 in Last 4 Hours, Started Today Down 6.82%; Price Base in Formation Over Past 14 Days – CFDTrading

Bitcoin Cash 4 Hour Price Update

Updated August 12, 2020 11:19 AM GMT (07:19 AM EST)

Bitcoin Cash closed the previous 4 hours up 1.53% ($4.34); this denotes the 2nd candle in a row it has gone up. Out of the 5 instruments in the Top Cryptos asset class, Bitcoin Cash ended up ranking 2nd for the four-hour candle in terms of price change relative to the previous 4 hours.

The back and forth price flow continues for Bitcoin Cash, which started today off at 281.77 US dollars, down 6.82% ($20.62) from the previous day. The price move occurred on stronger volume; specifically, yesterdays volume was up 44.14% from the day prior, and up 16.6% from the same day the week before. Out of the 5 instruments in the Top Cryptos asset class, Bitcoin Cash ended up ranking 4th for the day in terms of price change relative to the previous day. Lets take a look at the daily price chart of Bitcoin Cash.

First things first: Bitcoin Cash crossed below its 20 day moving average yesterday. Volatility for Bitcoin Cash has been contracting over the past two weeks relative to volatility over the past month. Whether volatility reverts will be something to watch. Trend traders will want to observe that the strongest trend appears on the 30 day horizon; over that time period, price has been moving up. Also of note is that on a 14 day basis price appears to be forming a base which could the stage for it being a support/resistance level going forward. For another vantage point, consider that Bitcoin Cashs price has gone up 15 of the previous 30 trading days.

For laughs, fights, or genuinely useful information, lets see what the most popular tweets pertaining to Bitcoin Cash for the past day were:

New Bitcoin Cash monthly report format coming tomorrow.

@CyPhlux What is the problem here?!? One thing is to be suspicious, but this is like holding BTC in 2017, before they forked it to Bitcoin Cash and then say-no thanks I dont want those tokens.

@KBClientPicks Im all about winning paper man. Bitcoin cash, Up here in Canada im a shark. Join me. Im darth vader be anakin !

Follow this link:

Bitcoin Cash (BCH) Up $4.34 in Last 4 Hours, Started Today Down 6.82%; Price Base in Formation Over Past 14 Days - CFDTrading

Coinbase Customers in Select U.S. States Will Soon Be Able to Borrow 30% of Their Bitcoin Holdings in… – Coinspeaker

Coinbase has unveiled its borrowing service which will go live later in the fall. Customers will get access to up to 30% of their BTC holdings.

At the heart of any business offering is the need to satisfy customers based on their consistent request. The Coinbase exchange, one of the worlds leading centralized cryptocurrency exchanges has come to terms with its customers request and is set to start giving out credit facilities in cash. The facility will be given to customers up to 30% of their Bitcoin (BTC) holdings.

We hear from customers that they need cash for expenses like home renovations or car repairs, but they do not want to prematurely sell their crypto, or take out high-interest loans that could come with 20%+ APR. With portfolio-backed loans on Coinbase, customers can borrow cash quickly from their Coinbase accounts. No need to fill out a long application or go through a credit check. Customers can simply sign up with a few taps and get the cash in their accounts within 23 days, Coinbase said in a statement.

The move by Coinbase exchange is similar to decentralized finance lending, a key trend in the crypto space as we have it today. Despite Coinbase being a centralized exchange, its move to delve into the world of lending shows in retrospect how flexible blockchain firms can be in responding to the worlds financial needs.

The Coinbase borrow service is scheduled to go live this fall and will be available in 17 states in the United States including New Jersey, North Carolina, New Hampshire, and Oregon amongst others.

Just as described, the borrowing process with Coinbase exchange will be more simplified when compared to what is obtainable in traditional banks. Through a simple online application filling out, customers can get their loans approved in 2-3 days. The Coinbase loan will be hedged against collateral which in this case is in Bitcoin.

This loan offering is unique as it will prevent customers from selling out their Bitcoins prematurely. The interest rate is pegged at 8% which is much lower than what is obtainable in banks. Each month, borrowers will only need to pay the interest accrued on the loan while and they can wait up to 1 year to repay the principal subject to Coinbase additional terms

While awaiting the official launch date, Coinbase is calling on eligible and interested customers to join the waitlist in order to have first-time access to the game-changing service.

The original purveyors of lending services in the blockchain ecosystem are DeFi platforms such as MakerDAO, Compound, and Aave amongst others. While the DeFi platforms loan service is similar to Coinbases version in terms of collateralization, the offerings differ in who takes the gain.

DeFi platforms are not just keen on bringing financial succor to the borrower, they aim for anyone with residual cash on their platform to benefit. This is unlike Coinbase which shares profit with no external parties.

The true manifestation of Decentralized Finance is to enable the comprehensive empowering of the masses, away from the grip of financial service providers who give little or no room for people to get to the point where they personalize their financial transactions.

While the Coinbase borrowing service is a key for a centralized exchange, its potential impacts are too soon to analyze but from the exchanges antecedents, this will be another service to extend its lead in the space.

Benjamin Godfrey is a blockchain enthusiast and journalists who relish writing about the real life applications of blockchain technology and innovations to drive general acceptance and worldwide integration of the emerging technology. His desires to educate people about cryptocurrencies inspires his contributions to renowned blockchain based media and sites. Benjamin Godfrey is a lover of sports and agriculture.

You have successfully joined our subscriber list.

Go here to see the original:

Coinbase Customers in Select U.S. States Will Soon Be Able to Borrow 30% of Their Bitcoin Holdings in... - Coinspeaker

The Crypto Daily Movers and Shakers August 8th, 2020 – Yahoo Finance

Bitcoin, BTC to USD, fell by 1.52% on Friday. Reversing a 0.20% gain from Thursday, Bitcoin ended the day at $11,580.0.

It was a mixed start to the day. Bitcoin rose to an early morning intraday high $11,900 before hitting reverse.

Falling short of the first major resistance level at $11,914, Bitcoin slid to a late afternoon intraday low $11,326.

Bitcoin fell through the first major support level at $11,581 and the second major support level at $11,402.

Finding late support, however, Bitcoin broke back through the second major support level to end the day at $11,580.

The first major support level at $11,581 pinned Bitcoin back late in the day.

The near-term bullish trend remained intact, supported by the latest move through to $11,000 levels. For the bears, Bitcoin would need to slide through the 62% FIB of $6,400 to form a near-term bearish trend.

Across the rest of the majors, it was a bearish day for the majors on Friday.

Bitcoin Cash SV (-4.48%), Cardanos ADA (-3.93%), Ethereum (-3.93%), Litecoin (-3.10%), Stellars Lumen (-3.44%), and Tezos (-4.53%) led the way down.

Binance Coin (-1.85%), Bitcoin Cash ABC (-2.15%), EOS (-2.54%), Moneros XMR (-1.10%), Ripples XRP (-2.87%), and Trons TRX (-1.83%) saw relatively modest losses on the day.

In the current week, the crypto total market cap rose from a Monday low $323.88bn to a Thursday high $355.09bn. At the time of writing, the total market cap stood at $342.33bn.

Bitcoins dominance fell from a Monday high 62.46% to a Tuesday low 61.24%. At the time of writing, Bitcoins dominance stood at 62.69%.

At the time of writing, Bitcoin was up by 0.17% to $11,599.6. A mixed start to the day saw Bitcoin fall to an early morning low $11,523.0 before rising to a high $11,608.0.

Bitcoin left the major support and resistance levels untested early on.

Elsewhere, it was a mixed start to the day.

Binance Coin (-1.02%), Cardanos ADA (-0.09%), EOS (-0.38%), Moneros XMR (-0.80%), Stellars Lumen (-0.02%), Tezos (-0.74%), and Trons TRX (-0.90%) saw red.

It was a bullish start for the rest of the majors, however.

Bitcoin Cash ABC was up by 0.22% to lead the way.

Bitcoin would need to move through the $11,600 pivot to support a run at the first major resistance level at $11,878.

Support from the broader market would be needed, however, for Bitcoin to break back through to $11,800 levels.

Barring an extended crypto rally, the first major resistance level and Fridays high $11,900 would likely cap any upside.

In the event of a crypto breakout, Bitcoin could eye the second major resistance level at $12,176.

Failure to move through the $11,600 pivot level would bring the first major support level at $11,304 into play.

Barring another extended crypto sell-off, however, Bitcoin should steer clear of sub-$11,000 levels. The second major support level at $11,028 should limit any downside.

This article was originally posted on FX Empire

Go here to read the rest:

The Crypto Daily Movers and Shakers August 8th, 2020 - Yahoo Finance

Global Impact of Covid-19 on Glutathione Market to Record Significant Revenue Growth During the Forecast Period 20202028 | KOHJIN Life Sciences,…

Informative Report On Glutathione Market 2020

Glutathionemarket has recently added by Grand View Reportto its massive repository. It offers the continual advancements in technologies which helps to understand the platform for the development of the businesses. It offers numerous strategies for boosting the performance of the companies. Both primary and secondary research techniques carried out to find solutions to different issues faced by various stakeholders.

Top Key Players Profiled in This Report: , Kyowa Hakko Bio, Shandong Jincheng, KOHJIN Life Sciences, Shenzhen GSH Bio-tech, Kaiping Biochemical Pharmaceutical, Gnosis SpA

Glutathione is a very small protein composed of only three amino acids (Glutamate, Glycine, and Cysteine). It is an important antioxidant in plants, animals, fungi, and some bacteria and archaea, preventing damage to important cellular components caused by reactive oxygen species such as free radicals and peroxides. It is can be widely used in pharmaceutical, health products, cosmetic and food additives.

Get a Sample (Use official email ID to Get Higher Priority) Report:https://grandviewreport.com/sample/2366

Covid-19 pandemic affects most industries in the globe. Here at Grand View Report we offer you comprehensive data of related industry which will help and support your business in all possible ways.

Segmentation across regions such as North America, Latin America, Asia-Pacific, Africa, and Europe was undertaken on the basis of productivity. Technological advancements pertaining to the specific market has been studied. Methodologies that can boost the outcome of the businesses have been mentioned in the report.

The Global GlutathioneMarket Can Be Segmented As

The key product type of Glutathionemarket are:, Reduced Glutathione (GSH), Oxidized Glutathione (GSSG)

GlutathioneMarket Outlook by Applications:, Pharmaceuticals, Health Products, Cosmetics, Food, Others

Significant Features that are under Offering and Key Highlights of the Reports:

Exclusive Upto 30% discount:https://grandviewreport.com/discount/2366

Key Questions responded in the report:

Table of Contents:

For More Details On this Report:https://grandviewreport.com/industry-growth/Glutathione-Market-2366

Original post:
Global Impact of Covid-19 on Glutathione Market to Record Significant Revenue Growth During the Forecast Period 20202028 | KOHJIN Life Sciences,...

Nanoscience Presents: Food Ingredient Formulation Development with Novel Real-time Technique – PR Web

QCM-D used for understanding the physical and biochemical characteristics of food ingredients at the molecular scale, mimicking real-time interactions for insights into food formulation.

PHOENIX (PRWEB) August 13, 2020

Nanoscience Instruments hosts researchers Dr. Alireza Abbaspourrad, the Yongkeun Joh Assistant Professor of Food Chemistry and Ingredient Technology, and his research associate, Dr. Younas Dadmohammadi as they present some of their novel findings during a free webinar on August 27th, 2020.

Understanding the physical and biochemical characteristics of food ingredients is a vital part of research in the fields of food chemistry and ingredient technology, especially as researchers make advancements toward natural and clean-label food ingredients. In Cornell Universitys Department of Food Science, part of the College of Agriculture and Life Sciences, the Abbaspourrad Lab is working on just that.

Food ingredients and their in-matrix interactions significantly determining the quality (i.e., color and texture) and perception profile (i.e., taste, flavor, and aroma) of food. Food shelf life is another critical factor influencing both quality and perception. Therefore, to move away from the old-fashioned method, cook and look, and embrace a more sustainable approach, the ingredient formulation is a key step. In this vein, understanding the physical and biochemical characteristics of food ingredients at the molecular scale and mimicking real-time molecule-molecule and molecule-saliva interactions yield insights into efficient food formulation and enhanced perception profile in the oral cavity. To achieve this goal and advance our understanding of food ingredients and turn that knowledge into practical applications, cutting-edge technology such as Quartz Crystal Microbalance with Dissipation is employed. Using this information, we can develop new formulations for food products with a better understanding of how the ingredients will play a role in food quality and desired perception.

In this webinar, we will discuss a couple of food applications using QCM-D information targeting (i) the encapsulation of bioactive component, N-Acetyl-L-Cysteine, to mask its off-flavor and (ii) improving the shelf life stability of Cphycocyanin (a natural blue colorant) in the beverage.

Register for the free webinar:https://bit.ly/2PVZjIF

For more information on the QCM-D technique visit nanoscience.com

About the presenters:

Alireza Abbaspourrad Bio:Dr. Abbaspourrad is an Assistant Professor of Food Chemistry and Ingredient Technology at Cornell University, Department of Food Science. He is co-author of 154 peer-reviewed publications and 13 provisional/granted patents. Due to his interest in microfluidic systems, he started to focus on microfluidic systems towards sperm sample preparation since September 2017, and so far, his group could file a patent on microfluidic-based sperm separation technology and submitted two papers in prestigious peer-reviewed journals. Dr. Abbaspourrad received his M.Sc. in Organic Chemistry from Ferdowsi University in Iran. He did his graduate work on synthesis and surface modification of zeolites at the Isfahan University of Technology, receiving his Ph.D. in Organic Chemistry in 2006 in Iran. He visited National Institute for Nanotechnology at the University of Alberta in Canada as a visiting scholar in 2003. Afterward, he established two chemical startups. In 2009, he joined Prof. David Weitzs group at the School of Engineering and Applied Sciences at Harvard University, where he studied fabrication of functional materials at interfaces, structural emulsions, encapsulation of ingredients, and controlled release systems using drop-based microfluidics as well as conventional microencapsulation techniques.

Younas Dadmohammadi Bio:Dr. Younas Dadmohammadi is a Research Associate at Cornell University. He is leading multi-disciplinary projects and mentoring a group of graduate and undergraduate students. His field of interest forges much-needed connections between engineering, food, and life science. Younas trained as a chemical engineer through a B.Sc., M.Sc., and Ph.D. from Iran. Younas has been experienced as an industry advisor for the chemical industry and served as faculty in universities for more than seven years. In 2009, Younas was invited to Texas A&M University as a Research Scholar working on cross-disciplinary projects. Then, he moved to Oklahoma State University, where he received his 2nd Ph.D. working on a DOE-funded project focusing on machine learning, modeling, and optimization integrating both microscopic and macroscopic scales. His findings were peer-reviewed and published in several papers. In 2014, Younas joined the industrial research consortium in Oklahoma, working directly with industry to raise funding and develop innovative solutions for industry challenges to minimize the research and development cost.

About Nanoscience InstrumentsNanoscience Instruments sells innovative and highest quality research and analytical instrumentation solutions. Servicing academia, industry and government partners by delivering specialty surface science instrumentations for nanoscale applications. Our portfolio consists of desktop scanning electron microscopes, nanofiber electrospinning instruments, nanoparticle generation instruments, sample preparation solutions, transmission electron microscopy solutions, micro-balance and contact angle tensiometery instrumentation. Visit nanoscience.com to learn more about the products as well as the consumables and accessories we provide.

Share article on social media or email:

Follow this link:
Nanoscience Presents: Food Ingredient Formulation Development with Novel Real-time Technique - PR Web

Floor-Standing Automatic Biochemical Analyzer Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies…

New Jersey, United States,- The most recent Floor-Standing Automatic Biochemical Analyzer Market Research study includes some significant activities of the current market size for the worldwide Floor-Standing Automatic Biochemical Analyzer market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centers around the Floor-Standing Automatic Biochemical Analyzer business status, presents volume and worth, key market, product type, consumers, regions, and key players.

The COVID-19 pandemic has disrupted lives and is challenging the business landscape globally. Pre and Post COVID-19 market outlook is covered in this report. This is the most recent report, covering the current economic situation after the COVID-19 outbreak.

Key highlights from COVID-19 impact analysis:

Unveiling a brief about the Floor-Standing Automatic Biochemical Analyzer market competitive scope:

The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

Floor-Standing Automatic Biochemical Analyzer Market, By Type

Floor-Standing Automatic Biochemical Analyzer Market, By Application

Other important inclusions in the Floor-Standing Automatic Biochemical Analyzer market report:

A brief overview of the regional landscape:

Reasons To Buy:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Protractor Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Pseudomonas Aeruginosa Infection Treatment Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Pull Out and Down Kitchen Faucet Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Pulpers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Pump Jack Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Here is the original post:
Floor-Standing Automatic Biochemical Analyzer Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies...

Floor-standing Automated Biochemical Analyzers Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies…

New Jersey, United States,- Market Research Intellect aggregates the latest research on Floor-standing Automated Biochemical Analyzers Market to provide a concise overview of market valuation, industry size, SWOT analysis, revenue approximation, and regional outlook for this business vertical. The report accurately addresses the major opportunities and challenges faced by competitors in this industry and presents the existing competitive landscape and corporate strategies implemented by the Floor-standing Automated Biochemical Analyzers market players.

The Floor-standing Automated Biochemical Analyzers market report gathers together the key trends influencing the growth of the industry with respect to competitive scenarios and regions in which the business has been successful. In addition, the study analyzes the various limitations of the industry and uncovers opportunities to establish a growth process. In addition, the report also includes a comprehensive research on industry changes caused by the COVID-19 pandemic, helping investors and other stakeholders make informed decisions.

Key highlights from COVID-19 impact analysis:

Unveiling a brief about the Floor-standing Automated Biochemical Analyzers market competitive scope:

The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

Floor-standing Automated Biochemical Analyzers Market, By Type

Floor-standing Automated Biochemical Analyzers Market, By Application

Other important inclusions in the Floor-standing Automated Biochemical Analyzers market report:

A brief overview of the regional landscape:

Reasons To Buy:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Dried Botanicals Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Dried Fruits Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Drill Pipe Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Drilling Jars Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Drinkware Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

View original post here:
Floor-standing Automated Biochemical Analyzers Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive Strategies...

Benzyl Carbazate Market share forecast to witness considerable growth from 2020 to 2025 | By Top Leading Vendors HIO Chemical, Binhai Hanhong…

Latest Research Report: Benzyl Carbazate industry

Benzyl Carbazate Market report is to provide accurate and strategic analysis of the Profile Projectors industry. The report closely examines each segment and its sub-segment futures before looking at the 360-degree view of the market mentioned above. Market forecasts will provide deep insight into industry parameters by accessing growth, consumption, upcoming market trends and various price fluctuations.

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

Benzyl Carbazate is a pesticide and pharmaceutical intermediate, mainly used for the synthesis of indoxacarb.

Benzyl Carbazate Market competition by top manufacturers as follow: , Amino Organics, HIO Chemical, Binhai Hanhong Biochemical, Vande Mark, Hunan Spark Science, Shandong Yinglang Chemical

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/123743

Global Benzyl Carbazate Market research reports growth rates and market value based on market dynamics, growth factors. Complete knowledge is based on the latest innovations in the industry, opportunities and trends. In addition to SWOT analysis by key suppliers, the report contains a comprehensive market analysis and major players landscape.The Type Coverage in the Market are: Purity:97%-99%Purity:>99%

Market Segment by Applications, covers:Pesticide ManufacturingPharmaceutical ManufacturingOthers

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaRest of Asia PacificCentral & South AmericaMiddle East & Africa

To get this report at a profitable rate.: https://reportsinsights.com/discount/123743

Important Features of the report:

Reasons for buying this report:

Access full Report Description, TOC, Table of Figure, Chart, [emailprotected] https://reportsinsights.com/industry-forecast/Benzyl-Carbazate-Market-123743About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

Here is the original post:
Benzyl Carbazate Market share forecast to witness considerable growth from 2020 to 2025 | By Top Leading Vendors HIO Chemical, Binhai Hanhong...

Eisai will shift U.S. HQ to New Jersey ‘bio-ecosystem’ in move to boost oncology, neurology portfolios – FiercePharma

Japanese drugmaker Eisai has established asolid foothold in the U.S. market and found some success with its Merck & Co.-partnered oncology med Lenvima. And alongside BIogen, it's in the FDA queue for a landmark decision in Alzheimer's disease.

But Eisai'sstateside ambitions are broader than thatand as if to illustrate that point, the company is plotting a new U.S. headquarters on a high-tech New Jersey campus.

Eisai will relocateits U.S. headquarters from Woodcliff Lake, New Jersey, to a 15-story complex at the ON3 "bio-ecosystem" in Nutley, New Jersey, by the end of 2021,the Tokyo-based drugmaker said Tuesday.

Accelerate Clinical Operations Across Sponsors, CROs, and Partners

The most advanced life sciences organizations know that digital innovation and multi-platform integrations are essential for enabling product development. New platforms are providing the life sciences industry with an opportunity to improve the efficiency of clinical trials and reduce costs while remaining compliant and reducing risk.

Eisai will be the first biopharma tenant at the 116-acre site,formerly Roche'sU.S. headquarters, alongside residents from the healthcare, R&D and diagnostics fields. All told, Eisai will ship 1,200 of its corporate and R&D employees to the site, which the drugmaker called "technologically advanced and cutting edge."

The move will give Eisai the opportunity to collaborate outside biopharma to boost its oncology, Alzheimer's disease and neurological portfolios, the company said. The location in a brand-new hub will also help Eisai recruit talented employees, a spokesperson said.

Eisai's relocation comes as the Japanese drugmaker works to boost its top-sellingoncology med Lenvima, which has found a promising partnership with Merck's Keytrudaalong with its share of setbacks.

Meanwhile, the drugmaker is also working with partner Biogen on controversial Alzheimer's drug aducanumab, which the FDA accepted for priority review last week.The agency expects to decide the fate of the treatment by March 7.

RELATED:Merck, Eisai's Keytruda-Lenvima combo stonewalled in liver cancer after Roche's first-in-class green light

That was a big loss for the duo, which still has just one FDA approval to its credit inendometrial carcinoma.The partners hoped an approval would put themup againstRoches pairing of immuno-oncology agent Tecentriq and anti-VEGF drug Avastin, which recently scoredan FDA nod in first-line liver cancer with gold-standard data showing they could help patients live longer.

The two companies are stilltesting the Keytruda-Lenvima combo as a first-line liver cancer therapy in the phase 3 Leap-002 study, which isfully enrolled.

RELATED:Eisai preps for launch with insomnia med Dayvigo after buying out Purdue

Meanwhile, Eisai has worked to flesh out its neurology business, scoring an FDA approval in December for Dayvigo, an insomnia castoff from Purdue Pharma.

Eisai took full ownership of Dayvigoin May 2019 after itbought outPurdue's stake in the drug in 2015.The drug is an orexin receptor antagonist that works by targeting the wake center of the brain, according to EisaiCEO and president of itsglobal neurology businessIvan Cheung, who called the approval "very exciting" at the time.

Read more from the original source:
Eisai will shift U.S. HQ to New Jersey 'bio-ecosystem' in move to boost oncology, neurology portfolios - FiercePharma

‘Covid fog’: The latest emerging, long-term symptom of Covid-19 – The Daily Briefing

Up to one-third of people who had Covid-19 report lingering neurological and psychological symptoms due to the disease, ranging from numb limbs to a mental slowness some people are calling "Covid fog"a finding that "reflect[s] a growing consensus that the disease can have lasting impact on the brain," Elizabeth Cooney reports for STAT News.

How Covid-19 will impact behavioral health services

According to Cooney, early reports from China and Europe revealed that some patients recovering from Covid-19, the disease caused by the new coronavirus, experienced anxiety and depression. Further, experts told STAT News that, in addition to mood disorders, they've seen patients who recovered from their coronavirus infections experience neuropsychological symptoms including dizziness, numbed limbs, brain fog, long-term loss of smell and taste, muscle weakness, and nerve damage so severe that patients struggled to walk. And that's on top of the long-term physical symptoms Covid-19 can cause, including damage to the heart, kidneys, and liver, Cooney reports.

Teodor Postolache, a professor of psychiatry at the University of Maryland School of Medicine, estimates that "between 30% and 50% of people with [a coronavirus] infection that has clinical manifestations are going to have some form of mental health issues," ranging from "anxiety or depression but also nonspecific symptoms that include fatigue, sleep, and waking abnormalities, a general sense of not being at your best, not being fully recovered in terms of the abilities of performing academically, occupationally, potentially physically."

John Bonfiglio, 64, reported many such symptoms after he recovered from a serious bout with Covid-19 at Newton-Wellesley Hospital, Cooney reports. Once Bonfiglio was finally transferred out of the ICUafter spending 17 days on a ventilatorhe said he was so confused that he forgot his name, forget where he was, and sometimes tried to slide from his bed to the floor.

Bonfiglio said he also felt more emotional than usual during his recovery and experienced persistent dizziness, hand tremors, and muscle weaknessso much so that he had to relearn how to walk. Bonfiglio said he's since regained some strength and the dizziness and tremors are now gone.

Similarly, Fred Pelzman, an internal medicine physician from New York who fell ill with Covid-19 in March, said he is still experiencing symptoms of the disease, including depressed abilities to taste and smell. And, according to Pelzman, his patients also have reported lingering effects from Covid-19, with one unable to complete simple math calculations in her head and others struggling to find correct words when communicating.

According to Cooney, researchers at the moment can say little "definitively about how best to prevent and treat neuropsychological manifestations of Covid-19. Nor do they know for certain why the brain is affected."

Victoria Pelak, a professor of neurology and ophthalmology at the University of Colorado School of Medicine, said treating Covid-19 patients with neurological symptoms has been like "trying to put out the fire." She explained, "Because you are so concerned with the raging fire," of Covid-19, "you haven't really been able to pay attention to the nervous system as much as you normally would."

But doctors have started putting some pieces together, Cooney writes. They think, for instance, that the new coronavirus damages the brain and nervous symptom through inflammation, not through a direct attack on those systems.

Lena Al-Harthi, chair of the department of microbial pathogens and immunity at Rush Medical College, explained that bits of the virusrather than the virus multiplyingcan spur the brain's inflammatory response.

"If you have an uncontrolled level of inflammation, that leads to toxicity and dysregulation," Al-Harthi said. "What I am concerned about is long-term effects, obviously in the [Covid-19 patients] who have been hospitalized, but I think it's definitely time to understand long-term sequelae for those individuals who have never been hospitalized"and it's not just limited to "older individuals," but includes "young [ones], too."

Physicians also are assessing whether the novel coronavirus is more likely than other viruses to cause a syndrome called demyelination, in which inflammation in the brain causes the immune system to attack the protective coating of nerve cells, Pelak said. According to Cooney, the syndrome can "cause weakness, numbness, and tingling. It can also disrupt how people think, in some cases spurring psychosis and hallucinations."

As for treating and preventing these longer-term issues, Ross ZafonteCMO at Spaulding Rehabilitation Hospital, which provides care to recovering Covid-19 patientssaid he's "trying to do a longitudinal study to see what are the comorbid factors." According to Zafonte, questions that need to be answered include: "What are the characteristics of people who don't get back to normal? How can early intervention try to deal with that? Are there some biomarkers of risk? [and] Can we try to define better targets for early intervention?"

Some physicians have voiced concerns about the long-term outlook for individuals who were infected with the coronavirus and are experiencing these symptoms. Postolache, for instance, said a coronavirus infection might serve as a "priming event," meaning that future stressors may reactivate the emotional and behavioral symptoms originally spurred by the infection. "We don't really say this is permanent," he said, "but considering all complexities of human life, it's unavoidable."

Wes Ely, a pulmonologist and critical care physician at Vanderbilt University Medical Center, echoed similar concerns, noting that while researchers will continue psychiatric evaluations and diagnostic imaging to get to the bottom of the symptoms, everything physicians know about the neurological symptoms of Covid-19 so far indicate that the disease could be "not only an acute problem," but "a chronic illness." Ely added, "The problem for these people is not over when they leave the hospital."

Keeping those factors in mind, Ely recommended three steps providers can take now to address the issue: "We can open the hospitals back up to the families" so patients are less isolated, "tell the families about [this issues] so that the families will know that this is coming," and offer "counseling and psychological help on the back end" (Cooney, STAT News, 8/12).

See the original post:
'Covid fog': The latest emerging, long-term symptom of Covid-19 - The Daily Briefing

Gilead, Maker Of Remdesivir, Criticized As ‘Taking Advantage Of The Situation’ – Kaiser Health News

Other pharmaceutical news is on orphan drugs, ALS trials, Theranos and more.

ABC News:For Company Behind Coronavirus Drug, Sharp Questions Over Pricing, Potentially Cheaper OptionAfter initial excitement about the discovery of a promising treatment for some coronavirus patients, executives with Gilead Sciences are now facing harsh criticism over the initial business decisions theyve made in the midst of a pandemic. In recent days, state leaders and a government watchdog group have leveled complaints against the company for the price point it set for its antiviral drug remdesivir, a promising treatment shown to diminish recovery time in hospitalized coronavirus patients, and for allegedly not more quickly pursing a potentially cheaper alternative. Gilead holds exclusive manufacturing rights for remdesivir. (Bruggeman, 8/13)

Stat:A Long-Awaited Report On Orphan Drugs In Europe Suggests Incentives To Pharma Need ChangeAfter being kept under wraps for a year, an expansive review of European regulations designed to spur development of drugs for rare diseases and children found the number of medicines has increased. But at the same time, drug makers often did not address some of the most urgent needs. Instead, the pharmaceutical industry sometimes targeted more profitable therapeutic areas, raising questions about whether incentives offered to the pharmaceutical industry should be changed, according to the long-awaited report from the European Commission. As in the U.S., these incentives include market exclusivity for a period of time. (Silverman, 8/12)

Boston Globe:'Were Going To Keep Going': A New Clinical Trials For ALS Gives Patients HopeAs a cardiologist, Dr. Marc Litt has plenty of arrows in his quiver for patients with heart disease: Medications that thin blood. Drug-coated stents that widen blocked arteries. Implants that replace damaged valves in minimally invasive surgery. But when the 63-year-old physician was diagnosed with ALS in March 2019 at Massachusetts General Hospital, he was dismayed to see how little medicine had to offer him. (Saltzman, 8/12)

In other pharmaceutical industry news

San Jose Mercury News:Theranos Founder Elizabeth Holmes Twice-Delayed Trial To Start In March: JudgeAfter being delayed twice by the coronavirus pandemic, the criminal trial of Theranos founder Elizabeth Holmes has been scheduled to start in March. Holmes, a Stanford University dropout who founded her now-defunct Palo Alto blood-testing startup in 2003, is charged with a dozen felony counts of fraud, and has denied federal government allegations that she and her co-accused, former company president Sunny Balwani, misled doctors and patients and bilked investors out of hundreds of millions of dollars. (Baron, 8/11)

Stat:4 Questions For Neurology Startups As Investment SurgesAs pharmaceutical companies stepped back from developing new drugs for neurological conditions, venture capitalists took a big step forward. Venture investors have poured more than $500 million into early-stage neurology startups this year, according to a recent health care venture capital report from Silicon Valley Bank more than six times as much money that was invested in the same over the first six months of last year. (Sheridan, 8/12)

CNN:CEO Does 180 Zoom Calls In Three Days To Help Take Company PublicBeing in charge of a health care company during a pandemic is a ton of work just ask Eric Hobbs, CEO of Berkeley Lights, who met with 180 investors over Zoom over three and a half days and lost 10 pounds over the process. You don't have to go on a virtual roadshow to work tirelessly in the drug business nowadays. Major drug companies are racing to develop a Covid-19 vaccine. But Hobbs says it won't be easy to come up with one that works right off the bat. (La Monica, 8/12)

More here:
Gilead, Maker Of Remdesivir, Criticized As 'Taking Advantage Of The Situation' - Kaiser Health News

How a Rural Hospital Developed and Launched its Telehealth Platform – mHealthIntelligence.com

August 11, 2020 -Small hospitals across the country are turning to telehealth to expand their treatment options and give patients access to specialists they might otherwise have to travel long distances to see. These services not only improve care for patients, but help the hospital to keep that care in the community.

Such is the case with the Beauregard Health System, an acute care hospital in rural DeRidder, LA. This past June, the 49-bed not-for-profit hospital launched a platform, through a partnership with SOC Telemed, to provide critical care, psychiatry, in-patient and emergency neurology and cardiology services via telemedicine.

The need for cardiology services was especially important. The hospitals only full-time cardiologist had left the previous April, and the hospital was transferring, on average, 30 patients each month to other hospitals.

Our community was vulnerable without a full-time local cardiologist, Traci Thibodeaux, MHA, CMPE, Beauregards chief operating officer, said in a press release. We wanted to partner with a cardiology group in Lake Charles, but knew they couldnt meet our needs for an onsite full-time physician.

In a recent Q&A with mHealthIntelligence, Thibodeaux explains how Beauregard planned out and launched its connected health strategy.

READ MORE: Telehealth Is The Best Tool in the Healthcare Toolbox for FQHCs

Q. What was the thinking behind deciding to partner with a telehealth company to offer these services on a telemedicine platform?

A. Beauregard Health System decided to partner with a telehealth provider because we needed to evolve from our grass roots approach and expand to include additional specialists - on one platform, using one process and the same equipment - to make it as seamless as possible for patients, nursing, and physicians.Since we are small rural acute care hospital, there are some specialties that we know well never offer locally.

Q. How were these 5 specialties psychiatry, critical care, inpatient neurology, emergency neurology and cardiology chosen? Were there specific arguments that these particular specialties need to be included in a telehealth strategy?

A. The specialties are critical for various reasons.

With psychiatry, our Emergency Department can get overwhelmed with trying to care for the sensitivities and complexities that this patient population presents.We have to consider patient safety, staff safety, and the safety of other patients and families, which includes children.We want all of our patients and families to feel safe and well cared for in our facility.

READ MORE: Telecritical Care Expands Telehealth From the ICU to Where Its Needed

Tele-psych consultation allows us to expeditiously determine the best and safest course and place of treatment, which often requires a transfer to a more appropriate care setting.

Cardiology and Neurology are important because, without these consultations, patients were automatically transferred to other facilities for a higher level of care, whether or not they truly needed it, since we werent able to offer on-site cardiology and neurology evaluations.

Telemedicine creates an opportunity to keep patients local when it is safe to do so.Our team on the ground, in consultation with a specialist who has assessed the patient, effectively care for many patients using this approach.This prevents unnecessary disruption for patients and families (and) prevents adding unnecessary direct and indirect cost of care for families, which includes transportation, travel, lodging, insurance, child care and missed work.

When we launched Tele-Critical Care in December of 2019, we had no way of knowing what a profound impact this would have on our patients, nurses, physicians and community.We were perfectly positioned to effectively care for every wave of COVID 19 that we first started seeing in March of this year at our hospital and through our current peak.This has allowed us to provide excellent care and weve undoubtedly gained a tremendous amount of community trust and support.

Q. What are the biggest challenges in launching a telehealth platform to address these services?

READ MORE: Senators Propose $50M Program to Fund RPM Pilots in Rural Areas

A. The biggest challenges were uncertainty of utilization and success.We questioned whether we would have a return on our investment with insurance plans reimbursing the service.We hoped that nursing would support the technology and see it as value-add for patient care.We prayed that the patient and family would have a great experience.We worried that we would have the WiFi and audio/video quality to support the interaction without interruption. We questioned whether the patient and family would have a good experience without the face to face interaction.

Q. How were clinicians and other staff brought on board? Was there any pushback or concerns about moving to telehealth?

A. The medical staff and board members were supportive of the project, but I might generalize that they were all cautiously optimistic going into this. Before COVID 19, the support of specialists were nice to have, but not essential, as we would transfer higher risk patients out for higher level of care.

Mid-pandemic, the medical staff and board have been so supportive that the telemedicine project has evolved and expanded into an organizational strategy.Tenured physicians who have practiced traditional medicine and bedside care are extremely supportive and accept that telemedicine is here to stay.

Ive (also) gotten additional feedback from nurses in the units who have learned from the online physician, as theyve had to be the hands of these virtual physicians.Nursing has to be on point in communicating vitals, assisting with the evaluation and assessment as directed by the on-screen physician and reporting pertinent details and changes in status.As one of our seasoned ICU nurses stated, I have to be prepared and on my game.Its made me a better nurse.

Q. Had you looked at other health systems/hospitals to see how they adopted telehealth? If so, what lessons were learned in how they did this?

A. At the time we were gearing up to launch telemedicine, our organization was also shopping for a new electronic health record. While we were checking references and networking with users of the various systems, we would ask about telemedicine and virtual visit capabilities.Most facilities had Tele-Stroke programs (as did we) but were not yet offering robust inpatient telemedicine services.

We had a need to stop unnecessary transfers; we realized that telemedicine was more of a sure thing than our ability to successfully recruit for the needed specialties. We decided to forge ahead with telemedicine and were determined to make the technical and logistics side work.At that point, the biggest wild card was whether the patient and family would have a positive experience and the service would add-value to our hospitalists and community physicians.

Q. What advice would you give a similar-sized hospital about launching a telehealth strategy?

A. Design your implementation strategy with a multi-disciplinary team. While medical staff and board support are certainly foundational to the strategic plan and investment, youve got to have champions -namely, physician (such as hospitalist leader or CMO), executive sponsor, IT, nurse leader, nurse educator, clinical workflow and documentation, heath information, contracting and revenue cycle.This team will have to collaborate on workflow, logistics and the what-ifs.

It is best to have folks involved on the front-end so that they buy in, remain engaged and have enough knowledge and familiarity to help trouble-shoot the workflow at go-live. If you have the right folks, a sense of pride and ownership develops, and failure is not an option.

Q. How will you measure success for these services? What benchmarks are being used to note whether a particular program is improving care or reducing workload stress?

A. We expect to see the number of patients we are transferring out by service line decrease, as compared to the baseline data prior to our telemedicine launch.We expect to find our case mix index trend up a little, as we are caring for slightly more complex patients relative to neurologic, cardiovascular and critical care. We expect a corresponding uptick in revenue relative to the level of care provided.

We expect to see physician satisfaction improve, since they will be better supported by specialists that we didnt previously have access to. We expect our patient experience to be impacted since the engagement between the patient and family and on-screen physician has been remarkable from a patient experience perspective.

For example, over the weekend we were able to keep and care for two neurology patients who we might have otherwise transferred out prior to telemedicine.Weve effectively cared for critically ill patients.Weve also been able to survive the challenges of the COVID 19 pandemic, while so many other hospitals have had to lay off staff or close their doors.In addition, weve provided our medical staff with access to specialists that we would not have otherwise had.

The most surprising aspect of our telemedicine program is how the nursing staff appreciates being able to provide more comprehensive care for their patients, how the nursing staff is able to learn from the on-screen physician, and how well-received the service has been with our patients who had mostly only been exposed to face-to-face care.

Q. How will you scale up or expand your telehealth strategy in the future?

A. We look forward to launching virtual visits in conjunction with our patient portal and the new EHR, which goes live January 1, 2021. We are exploring other specialties and virtual services (and) are open to any virtual opportunity that is affordable, sustainable, and adds value to our patients and medical staff.

Q. What can or could state and federal officials do to help hospitals like yours use more telehealth?

A. The loosening of some regulations related to telemedicine has been a great start, but it is in response to COVID 19, and were not certain what the new regulatory normal looks like.Especially burdensome for providers is the ongoing battle with insurance plans to figure out which hoops they require to approve services and then, even more challenging, is how to get reimbursement.There are very few standard rules of engagement. Every plan has its own requirements and nuances, which is frustrating, discouraging, labor intensive and costly.

Especially for rural communities, we need more planning and investment in infrastructure to support access to care, such as fiber networks, affordable internet and device availability for home monitoring systems for elderly and other at risk populations.Additionally, shifting focus to programs that support more population health initiatives and comprehensive and sustainable programs to close the gap on disparities in health care is crucial.

Continue reading here:
How a Rural Hospital Developed and Launched its Telehealth Platform - mHealthIntelligence.com

COVID And The Brain: ‘You Should Be Afraid’ – KPBS

Horror explores themes relating to the brain be it about disembodied brains on a rampage or how someone can control your mind or what happens to your gray matter when you're zombified. Now COVID-19 is serving up real horrors about how it can affect the brain. UC San Diego Health neurointensivist Dr. Navaz Karanjia explains what the dangers are.

Aired: August 10, 2020 | Transcript

"World War Z" novel by Max Brooks

"The Mind Explained" documentary

"Memento" narrative film about amnesia

Horror frequently explores themes relating to the brain be it about disembodied brains on a rampage or how someone can control your mind or what happens to your gray matter when you're zombified. Now COVID-19 is serving up real horrors about how it can affect the brain. UC San Diego Health neurointensivist Dr. Navaz Karanjia explains what the dangers are.

As someone who is fascinated by how the brain works, I love when pop culture finds creative ways to explore our fears and fascination with an organ that still mystifies us on many levels. This leads me to something else I love, picking the brains of neuroscientists. In this case I spoke with Karanjia about how COVID affects the brain, which is an area of the virus that I have not seen discussed that often.

Karanjia's specialty is neurocrtical care, and the technical term for her position is a neurointensivist, which she said "means I take care of any patient who has a brain problem severe enough to land them in the ICU, so I take care of patients with strokes, seizures, bad brain tumors, brain hemorrhages, brain infections, brain trauma, etc."

How COVID attacks the brain

Now her area of expertise is being tapped as doctors are seeing more neurological complications from the coronavirus.

Karanjia outlines three ways by which COVID can attack the nervous system: "One, by direct viral invasion, coming through the bloodstream or by infecting the nerves in the nose the olfactory nerves that are attached to the brain and crawling along them to the brain. Two, by the body creating antibodies that attack the brain and nervous system. And three, by causing systemic inflammation to the other organs and blood vessels that can cause blood clots to form all over the body, that may get shot up through the heart to the brain, or that may form in the brain itself.

But there are some facts emerging about the virus and the brain.

"The thing that's tragic and fascinating about COVID is it can affect the brain and nerves in so many different ways," Karanjia said. "For example, the damage it causes to blood vessels can lead to strokes and brain hemorrhages in up to 6% of hospitalized patients. Low oxygen levels caused by the lung and heart injury can damage the brain. And the inflammation itself from the infection can affect the brain and the nerves, causing confusion and delirium in the majority of patients with severe COVID. It can also directly affect the nervous system. In mild cases, it can cause loss of taste or smell, or in severe cases it can cause meningitis. We've also seen it cause, an autoimmune reaction, where the body's antibodies to the virus accidentally attack the brain and nerves, and that can cause life threatening issues like brain swelling and Guillain-Barre syndrome."

And finally, there are psychiatric symptoms that are being reported.

"We're seeing people with hallucinations, even psychosis, even after mild COVID disease, which could be from brain involvement," Karanjia said. "One COVID patient in her 50s, with no psychiatric history, with mild symptoms of fever, cough, and loss of taste and smell, was hospitalized for three days requiring minimal oxygen treatment. After discharge her husband reported she was confused and doing strange things like taking her coat on and off repeatedly, and reporting visual hallucinations of monkeys in her house, as well as auditory hallucinations. And then there's the anxiety, depression and PTSD due to the psychological trauma of being hospitalized with a frightening disease."

The neurological problems related to COVID can range from mild like headache or loss of taste and smell, which have been commonly documented in symptomatic patients, to more concerning things like difficulty concentrating or thinking, which has been called brain fog, to confusion and delirium. The virus is creating neurological complications by causing strokes or depriving the brain of oxygen as well as by attacking the brain cells directly.

"So there are plenty of reports of meningitis and encephalitis, or inflammation of the brain, from the virus infecting the brain," Karanjia stated. "We also know that even in minimally symptomatic patients, when they have an MRI, they can demonstrate evidence of inflammation of the brain even if they don't have neurologic symptoms. So the exact number of patients that that are having neuro-invasion is unclear. But because an early symptom of COVID is commonly the loss of smell and taste, which is carried by the nerve from the nose that goes directly to the brain, the olfactory nerve, we are concerned that direct invasion of the neuro-system is happening in a much larger percentage of patients than we would normally expect with a virus like this."

COVID and strokes

The damage a stroke can cause to a patient is something that doctors are familiar with. Karanjia is particularly concerned with how COVID can create these life threatening complications.

"We've seen, strokes from those blood clots I talked about, brain swelling, seizures, coma from infection and inflammation of the brain, paralysis from autoimmune attacks on the nerves, she said. What I'm seeing most commonly is delirium in the very sick COVID patients. And we've seen a number of strokes as well, both of which can have permanent consequences. Although they happen more frequently, the more severe the patients COVID symptoms, it's important to note that these neuroemergencies can even happen to patients with mild respiratory symptoms. We've seen some young patients with minimally symptomatic covid with no stroke risk factors come in with devastating large strokes."

Karanjia wants people to be aware of the symptoms that signal a stroke be it from COVID or from other health reasons.

"One of the ways to remember the symptoms of stroke is the mnemonic BE FAST," she explained. "B for sudden balance problems. E for sudden eye or visual problems. F for facial drooping. A for arm weakness. S for speech problems. And T is time to call 911 because we have excellent treatments for stroke that can return up to 70% of patients back to a functional life, but they only work if they're started within hours of symptom onset 2 million neurons are dying every minute you're having a stroke. So that's why it's so important to call 911 immediately. And that's not an exhaustive list of all the symptoms that could be indicative of neuro complications. If you see somebody convulsing, confused, sleepier than usual, with a bluish tinge to their face, or just generally not acting like their normal self. Call 911."

But Karanjia also wants to point out that there are effective treatments for some of the side effects COVID is causing.

There are a number of promising medications under investigation. But of course, the best treatment will be to prevent getting it in the first place, Karanjia said. We already have excellent treatments for stroke. For example, we have clot busting drugs and procedures to remove brain clots that can return folks to a functional life up to 70% of the time as long as they reach the hospital within hours of their symptoms. And we also have excellent neurocritical care treatments for the other conditions.

Long term effects of COVID

Again, since coronavirus is a novel strain that doctors and scientists have not seen before, there is no way to know what the long-term effects of the disease might be. So even if you have recovered from the obvious symptoms of COVID you may have lingering problems for an as yet unknown length of time.

"On MRI, some patients with no symptoms except for loss of smell have brain inflammation. And for some of those patients, their symptoms are still ongoing. So we don't know how long they will last or what percentage of people will get them or whether there are other long term effects. That's why there are studies going on to investigate those long term effects," Karanjia said.

One of the unique things about COVID is the effect it has on the blood vessel lining that causes clots everywhere in the body.

This is not something we've seen from common viruses before, and that's why the effects of COVID seem to be more devastating and causing more widespread organ damage than we're used to seeing with other viruses," Karanjia said. "In addition to the specific effects of COVID, we are also concerned about the number of patients that may develop Post Intensive Care Syndrome, or PICS, which can cause memory and thinking problems similar to Alzheimers Disease, psychiatric problems like PTSD, and physical problems like ongoing fatigue and weakness. Up to 50% of patients that survive an ICU stay can develop PICS. PICS clinics and COVID neuro clinics are now opening around the country to help patients with these long term effects."

What being a novel coronavirus means

COVID-19 is a novel coronavirus and that means scientists have only been able to study it since it was first discovered late last year. That also means new information is continually being discovered as studies evolve with more patients over more time.

"Any new disease is a challenge because there's limited data at first," Karanjia explained. "It takes years to design studies, recruit patients and perform the study in a scientifically rigorous and ethical way. But now you've got a highly infectious disease that progresses rapidly over days to weeks. The longer-term effects will take time to discover. So, for example, during the Spanish flu pandemic of the early 20th century, nobody knew what the effects would be on babies. So we needed decades of follow up to discover what those effects were."

But with the Internet, social media, and the politicizing of the pandemic there is a lot of misinformation and changing information that can be difficult for people to filter through. A similar situation occurred during the Spanish flu.

Unfortunately, during the Spanish flu pandemic, for example, people were also desperate, she said. Some were hawking quinine as a treatment, which it's not for the flu, and protesting against mandatory mask laws then as well. But as it became clear that quinine didn't work against the flu and mask wearing did help people eventually came around, as I am optimistic they will today. So, yes, it is a challenge to get good information out there because it takes time to do good studies and then get the answers out there in a way so people know they're legitimate. But what's important for people to understand is that scientists are still going through the process of doing those studies and we need patients help to participate in them so we can understand this disease.

Bottom line: 'Wear a mask!'

When I asked Karanjia for this interview, I had explained my love of pop culture and had mentioned Max Brooks' novel "World War Z." That inspired her to read the book, which we discussed.

"I think there are a number of things that Max Brooks got right in his zombie apocalypse book," she said. "So one of the most salient ones, I think, is because no one wanted to believe that a serious pandemic was occurring in the book. There was a delay in using the right tactics to combat it, which resulted in a lot of preventable death and suffering. So while COVID is not a zombie apocalypse, it would be great if we could learn from 'World War Z,' take this pandemic seriously and initiate appropriate containment tactics to prevent it from snowballing as opposed to the book."

If there is one thing Karanjia hopes people take away from her discussion here it's this:

"You SHOULD be afraid of getting COVID, because Ive seen it kill young healthy people or leave them horribly disabled," she told me. Many of my patients' families chose to let their loved ones die because the brain damage they sustained was so severe. I have now seen multiple young COVID patients with neurologic complications that resulted in their death or left them terribly disabled. I have not seen that with the flu in over 15 years of treating patients. We can get through this faster and with less economic damage and lives lost if we all wear masks and social distance.

It is really that simple.

Beth Accomando Arts & Culture Reporter

I cover arts and culture, from Comic-Con to opera, from pop entertainment to fine art, from zombies to Shakespeare. I am interested in going behind the scenes to explore the creative process; seeing how pop culture reflects social issues; and providing a context for art and entertainment.

To view PDF documents, Download Acrobat Reader.

Read the original here:
COVID And The Brain: 'You Should Be Afraid' - KPBS

Uncovering the neurological connections to COVID-19 | Penn Today – Penn Today

More than seven months into the battle against COVID-19, scientists have gained a better understanding of the disease and its symptoms while finding new and improved ways to test and treat patients. But countless mysteries remain. Why does COVID-19 cause some patients to lose their sense of smell and taste? What are the psychiatric andneurological complicationsnow associated with COVID-19 infectionsand can these issues be prevented?

Currently, there are a variety of research efforts across Penn to uncover the neurological implications of the disease, including stroke, neuroinflammation, and loss of smell.

Even thoughinitialreportssuggested a significant risk of stroke in patients hospitalized with COVID-19, research led byBrett Cucchiara, an associate professor of neurology at the Perelman School of Medicine, published inStroke, showed a low risk.

Yes, there is a connection between stroke and COVID-19, but we dont want people to overly worry about this, Cucchiara says. Its important to understand that the risk of stroke for those suffering from COVID-19 is fairly lowits impacting about two percentof patients hospitalized for the virus. And for every patient hospitalized, there are maybe 10 or 20 who arentperhaps even more considering those who are asymptomatic. That small percentage still merits continued investigation, Cucchiara added. He and his team are continuing to look at the linkage between stroke and COVID-19 to learn more about the virus and improve treatment for patients.

Read more at Penn Medicine News.

See original here:
Uncovering the neurological connections to COVID-19 | Penn Today - Penn Today

icometrix named to the 2020 CB Insights Digital Health 150 – List of Most Innovative Digital Health Startups – PRNewswire

NEW YORK, Aug. 13, 2020 /PRNewswire/ --CB Insights today named icometrix to its second annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world.

The 2020 Digital Health 150 cohort highlights startups that are reimagining the lines of the traditional healthcare experience across 12 categories, from Virtual Care Delivery and Clinical Trials, to Drug Discovery and Specialty Care.

"This year's Digital Health 150 is our most global ever, covering the best private healthcare companies from 17 countries. Beyond geographic diversity, these companies are innovating across the entire healthcare value chain, spanning technologies that benefit pharma & biotech companies, to payers, hospitals, insurers, and more," said CB Insights CEO Anand Sanwal.

"We are honored to receive this renewed recognition by CB Insights," said Wim Van Hecke, CEO of icometrix. "Innovative digital health solutions are changing healthcare at a rapid pace. Through our brain MRI and CT measures, we help radiologists, neurologists, neurosurgeons, and their referring physicians to make more informed and more accurate decisions for patients with neurological disorders. With our recently launched icompanion, a free app for people with multiple sclerosis to track symptoms, treatments, physician visits, as well as view their MRI scans on-the-go. All of this contributes to enhanced patient care worldwide, providing individual patients with the right treatment at the right moment," Van Hecke concludes.

icometrix offers AI solutions to obtain clinically meaningful data from MR and CT scans. Its icobrain portfolio incorporates brain volumetrics for patients with neurological conditions in clinical practice. icolung, an AI solution launched to help fight COVID-19, quantifies lung pathology on chest CT in admitted COVID-patients. Today, icometrix is internationally active in over 100 clinical practices and works with healthcare providers and pharmaceutical companies on the evaluation of drug trials for neurological diseases.

About icometrix icometrix (Leuven, Belgium; Chicago, USA) is the world leader in software solutions to obtain clinically meaningful data from brain MRI and CT scans. The fully automated icobrain software has market clearance in the USA, Europe, Japan, Canada, Brazil, India, and Australia. Today, the icobrain portfolio is used in patients with multiple sclerosis, dementia, and brain trauma.

Contact: Wim Van Hecke, CEO[emailprotected]+32 16-369-000icometrix.com

Press Kit:https://icometrix-files.s3-eu-west-1.amazonaws.com/Press-releases/Press-Kit-icometrix-20200813.zip

SOURCE icometrix

http://icometrix.com

Read the original:
icometrix named to the 2020 CB Insights Digital Health 150 - List of Most Innovative Digital Health Startups - PRNewswire

Why COVID-19’s long-term health effects are a cause for concern – Arab News

DUBAI: What was first identified as another respiratory disease akin to the common flu has taken the lives of over 600,000 people around the world in just six months.

The latest strain of the coronavirushas been described as an invisible enemy, slowly revealing new symptoms as the global scientific community continues investigations into it.

Since the first outbreak of the coronavirusdisease (COVID-19), traced to a wet market in Wuhan, China, in late 2019, the infection quickly developed into a full-fledged pandemic, with over 15 million cases reported to date. Symptoms have multiplied, leaving puzzled experts determined to find a cure.

Findings published this month appear to confirm growing concerns about the infections link to serious and potentially fatal brain disorders as well as cardiovascular complications.

Chief Scientific Officer Dr. Jeff Drew carries out research into the virus at the Stabilitech laboratory in the UK. (AFP)

Were seeing things in the way COVID-19 affects the brain that we havent seen before with other viruses, said Michael Zandi, a consultant neurologist at the National Hospital for Neurology and Neurosurgery in London, after the publication of new research in the scientific journal Brain.

Common flu-like signs such as fever, dry cough and sore throat were the first set of symptoms reported at the start of the pandemic. However, the list rapidly expanded to include shortness of breath, loss of taste and smell, nausea and several more symptoms just months later.

Today, the biggest concern among health professionals is the virus insidious impact on the brain, with more than 300 studies of COVID-19 patients worldwide showing neurological abnormalities.

One study published in Brain involving 43 patients 24 males and 19 females confirmed a range of neurological complications in mildly affected and recovering patients.

Commenting on the new findings, Gregory Poland, an infectious diseases and vaccine expert at the Mayo Clinic in Rochester, Minnesota, said the virus impact on the brain is variable and can range from having no visible impact to causing large vessel occlusions, known more commonly as very large strokes.

With the virus refusing to discriminate based on age or color, severe cases have been reported among young and relatively healthy individuals as well as those with pre-existing conditions and the elderly.

Gregory Poland, an infectious diseases and vaccine expert at the Mayo Clinic in Rochester, Minnesota

Obviously, the risk goes higher the more severe the disease; large vessel occlusions in young people have occurred with moderate to severe COVID-19 cases. But it can happen to people anywhere along that spectrum, Poland told Arab News.

In the neurologic realm, the studys findings showed that patients suffered from encephalopathy; stroke; inflammation of the central nervous system; peripheral nerve problems; cognitive and mental health issues, with delirium, psychosis and several cases of Guillain-Barre syndrome, an immune reaction that attacks the nerves and causes paralysis.

Dr. Taoufik Al-Saadi, chief medical officer and chair of the Neurology Department at the American Center of Psychiatry and Neurology in the UAE

Other symptoms included depression, anxiety and brain fog as well as a loss of smell, taste and sleep in mild and asymptomatic patients.

Another study, Neurological associations of COVID-19, published on the Lancet Neurology website, confirmed that a growing number of case reports and series from around the world described the same array of neurological manifestations, noting the virus is of a scale not seen since the 1918 influenza pandemic.

According to Poland, health care systems are recognizing that theres going to be a greatly enhanced need for rehabilitation and recovery centers after the COVID-19 pandemic as a result of the latest outcomes.

His views are echoed by Dr. Taoufik Al-Saadi, chief medical officer and chair of the Neurology Department at the American Center of Psychiatry and Neurology in the UAE, who pointed out that although most individuals are inclined to experience a mild or asymptomatic disease course, some have required ventilatory support.

Data suggest that one in five infected individuals are hospitalized, and one in 10 individuals are admitted to the intensive care unit (ICU), requiring ventilatory support, due to acute illness in response to this infection, he said.

The main issue in survivors of these cases is the physical, cognitive and mental impairment that may persist for several years beyond hospital discharge. Indeed, 80 percent of ICU survivors with confirmed COVID-19 may follow that course, Al-Saadi told Arab News.

Cases of memory impairment, depression, anxiety, post-traumatic stress-like disorders have all been reported in up to 30 percent of these patients and may last up to several years following hospital discharge, said Al-Saadi.

These complications would certainly affect survivors of this disease in all aspects of their everyday life whether functioning at work, home or in the social sphere, he said.

Additionally, cognitive, physical and mental problems could result in chronic pain conditions, further causing sleep disorders, which could ultimately affect the overall quality of life. What frightens the scientific community even more is that the long-term impact of such neurological effects has not yet been determined.

However, the virus potential long-term health effects do not stop at causing damage to the brain. Scientists are increasingly recognizing the cardiovascular side effects of the virus, with reports of markers of cardiac injury even in young people.

According to Poland, cases of COVID-19 have resulted in inflammation of the heart (myocarditis), decreased heart-muscle function (cardiomyopathy), irregular heart rhythms (arrhythmias) and dilation of coronary and other blood vessels due to vascular inflammation as well as blood clots.

For patients with a prior history of cardiovascular disorders and increased risk factors, such as hypertension and diabetes, chances of heart complications significantly rise when infected with COVID-19.The British Heart Foundation confirms these findings, noting that this strain of the virus has been found to increase the risk of blood clotting or thrombosis, leading to cardiovascular problems and, in some cases, organ failure.

The term COVID toe has also been coined in reference to painful red or purple swollen patches on the feet, usually the toes of infected patients, a condition known as Chilblains and typically associated with exposure to cold weather.

Some experts have linked COVID toe to blood clots and other neurological issues caused by the virus.

Examining the plethora of symptoms and conditions triggered by the virus, Poland believes experts must not yet discuss the long-term health effects of COVID-19 on patients as research is still in its infancy.

What we can say is that early indicators of pulmonary fibrosis and scarring are irreversible. We have seen myocarditis and cardiomyopathy, some of which can improve, but we dont know if they will completely improve, he said.

Poland also referred to a group of patients he calls the long-haulers who have developed almost a chronic fatigue-like symptom accompanied by an assortment of symptoms as result of infection with the virus. For these patients, the virus impact is long-lasting.

Evidence of kidney and liver damage has also been reported in cases around the world, with no clear indication of the long-term consequences.

Similarly, the impact of COVID-19 on pregnant women and their unborn children is yet to be defined with certainty.

With science yet to answer so many questions, Polands prognostication is no more reassuring than the available findings on virus. My guess, he said, is that young, healthy people will recover, and older people will have a more difficult time getting back to baseline, if at all.

--------

Twitter: @jumana_khamis

Read more from the original source:
Why COVID-19's long-term health effects are a cause for concern - Arab News

Neurovascular or Interventional Neurology Devices Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive…

New Jersey, United States,- Market Research Intellect aggregates the latest research on Neurovascular or Interventional Neurology Devices Market to provide a concise overview of market valuation, industry size, SWOT analysis, revenue approximation, and regional outlook for this business vertical. The report accurately addresses the major opportunities and challenges faced by competitors in this industry and presents the existing competitive landscape and corporate strategies implemented by the Neurovascular or Interventional Neurology Devices market players.

The Neurovascular or Interventional Neurology Devices market report gathers together the key trends influencing the growth of the industry with respect to competitive scenarios and regions in which the business has been successful. In addition, the study analyzes the various limitations of the industry and uncovers opportunities to establish a growth process. In addition, the report also includes a comprehensive research on industry changes caused by the COVID-19 pandemic, helping investors and other stakeholders make informed decisions.

Key highlights from COVID-19 impact analysis:

Unveiling a brief about the Neurovascular or Interventional Neurology Devices market competitive scope:

The report includes pivotal details about the manufactured products, and in-depth company profile, remuneration, and other production patterns.

The research study encompasses information pertaining to the market share that every company holds, in tandem with the price pattern graph and the gross margins.

Neurovascular or Interventional Neurology Devices Market, By Type

Neurovascular or Interventional Neurology Devices Market, By Application

Other important inclusions in the Neurovascular or Interventional Neurology Devices market report:

A brief overview of the regional landscape:

Reasons To Buy:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Our Trending Reports

Gas Incubator Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Gas Mixers Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Gas Powered Chainsaws Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Gas Pressure Regulator Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Dealer Management Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

The rest is here:
Neurovascular or Interventional Neurology Devices Market 2020 Size by Product Analysis, Application, End-Users, Regional Outlook, Competitive...

Will There Be Sooner Football In 2020? – Sooner Maven

The word from SI's Pat Forde this morning isn't what you would call encouraging.

In a year that's brought an absolute avalanche of bad news, the gut punch for college football fans across the nation could be on the horizon.

Yep.

It's admittedly very hard to take this at face value without verging on nihilism. After all, it's been nearly five months since the sports world ground to an unprecedented halt and went into a virtual shutdown. By all accounts, this entire saga was supposed to be over by now. COVID-19 was supposed to have been ancient history by the time football season rolled around.

And yet here we are on Aug. 8, very much on the precipice of truly uncharted territory. Not since the MLB's 1994 strike has there been such an impactful stoppage of play across American sports. And let's be honest: 2020 transcends any comparison. This isn't a strike. This is a pandemic, and there's frankly no end in sight at the moment.

To offer conjecture here would be pointless. There is no shred of certainty as to what the coming days or even the coming hours will bring. But though it may be the harshest of realities, it's time to square up with the fact of the matter.

There may not be Sooner football in 2020.

The MAC announced today that they intend to postpone football until the spring. Several FCS conferences have done the same. Yahoo Sports' Pete Thamel tweeted that the Big Ten could be close to issuing a similar ruling.

Let's recall that the Big Ten was first through the wall in cancelling its schools' nonconference games, a precedent that every other Power 5 conference eventually fell in line with.

None of this bodes well for the prospect of a football season this fall.

Lincoln Riley and the Sooner staff have done a tremendous job adapting to a changing environment and keeping the Sooners completely free of COVID-19. But they're the exception, not the rule. Oklahoma's near-flawless response to the virus simply hasn't been emulated or duplicated at other programs across the country, and even the most airtight plans can't account for the relentless machinations of the inhuman juggernaut that is COVID-19.

In an ideal world, the Big Ten presidents convene and decide to move forward with their conference-only plan, preserving some semblance of a path for Power 5 football to happen this fall. But how many times over the course of the year 2020 have we operated under the premise of "an ideal world," and how many times has the resulting scenario come to fruition?

We can continue to hope for the best. But it looks like it's come time to start preparing for the worst.

Turn your social media notifications on now, because today is shaping up to be another landmark day for college athletics.

To get the latest OU posts as they happen, join the SI Sooners Community by clicking Follow at the top right corner of the page (mobile users can click the notifications bell icon), and follow SI Sooners on Twitter @All_Sooners.

Original post:

Will There Be Sooner Football In 2020? - Sooner Maven

Walking with the Wind – TAPinto.net

Reflecting on the words of the great John Lewis, which were printed after his death, I am struck by the importance, especially in 2020, to heed his directive that voting and participating in the democratic process is a key.

His admonition is not a foreign concept to me. My father taught my sister and me that, as citizens, it was our duty to share in the democratic process, which included paying close attention to current affairs. I remember at age 12 taking some of my hard-earned money washing cars to buy a five-year subscription to Time magazine, which I dutifully read each week. In the Martorano household, the nightly news and, of course presidential press conferences and addresses, were mandatory viewing and were witnessed without complaint or distraction.

We listened attentively to the words of presidents Eisenhower, Kennedy and Johnson as history was made right before our eyes. Later, when I was on my own, my interest in public affairs only intensified. Looking back over the hundreds of speeches and addresses that I have taken in over my lifetime, I must confess to having been inspired countless times by soaring rhetoric, which as a general rule, called on us to reach higher, try harder and never give up our efforts to achieve and maintain the true promise of America.

Our newsletter delivers the local news that you can trust.

My dad was a diehard Republican. Yet, as partisan as he was, he still believed that all of us (Democrats and Republicans) were members of the same choir; we just had different verses. He believed to his dying breath that, when all was said and done, we all shared the same values; we just prioritized them differently. He taught my sister and me that no matter your political stripe, you had a duty to join your fellow citizens in working to improve the lives of all people within the framework of our democratic process.

Yet, over the last two decades, there has been a societal erosion of my fathers belief that we are all members of the same choir. We have been witness to the unmistakable introduction of a nihilistic thread into our countrys consciousness and political system.

Historically, nihilism, as an epistemological term, references a small branch of philosophy that asserts that nothing is knowable or worth knowing. However, the nihilism I refer to today is that which can be assigned more appropriately to the world of ethics. Nihilism, in this sense, maintains that all moral judgments are irrational, relative, and finally meaningless. Once accepted either intellectually or merely in practice, it frees its proponent from the shackles of duty, truth, or even morality in general.

When I speak of todays nihilism, I am not referring to the mistrust of government that is a perennial feature of democracy. As a Yorktown councilperson, I remember recoiling in horror whenever I overheard someone comment with conviction that all politicians are corrupt. Although I found such beliefs insulting, I always understood that the questioning of a skeptical public was a healthy tool in keeping government on its toes. Nor am I referencing the mantra of first-time candidates (which I had to endure on several occasions) that it was time for a change. That expression inferred, ever so gently, that if you are in office a long time, either staleness or corruption is inevitable. These types of cynicism, far from being malevolent, have often proved effective in holding elected officials accountable.

The nihilism I am referring to, so widespread today, is much more sinister and exponentially more dangerous to a democracy than the normal skepticism voiced by an electorate often hungry for new voices. The underpinnings of the modern-day version are simple: there is no morality, good and evil, right or wrongonly power. This view rejects an objective reality, science, accountability, ethical standards, morality, honor or equity. Its goal is no less than the annihilation of our faith in our democratic institutions themselves. Historically speaking, this type of dark sentiment has always thrived best during times of marked societal apprehension.

Ivan Turgenevs novel in 1862, Fathers and Sons, popularized nihilism as a repudiation of an utterly corrupt political and legal system. Unlike todays version, it concurrently offered a vision of a better world. But most of us associate nihilism with the prominent German philosopher, Friedrich Nietzsche. Although I doubt he ever envisioned the present misuse of his ideas, Nietzsche wrote about a Superman (Zarathustra) who, liberated from the constraints of culture, religion, and ethics, was free to assert himself in the world. Nietzsche was reacting to what he considered the religious and cultural straightjackets of his time, which he believed stifled the creative process. Even though he never intended it, his conception of an existential Superman was, after his death, perversely misused by tyrants to justify their advancement of authoritarian political systems.

Nihilism in 2020 flourishes in a jittery world full of conspiracy theories, a pandemic crisis, economic dispossession, and virulent racism. Its twin emotional engines of fear and hatred are easily manipulated by bad actors that have the perverse skill to use it to their advantage. Todays conspiracy theories are actually devoid of theory. Their methodology is the repetition of bold-faced lies (without a shred of evidence) designed to feed this new destructive impulse, which undermines faith in our democratic institutions. Once the nihilists goal has been achieved, the converted have lost all belief in, or need for, science (or rationality for that matter), the truth, social justice, the law, or any ethical conceptions of morality or equity.

Removed from the constraints of morality, tradition, ethics, much like Nietzsches Superman, all that matters for todays nihilist is a brute existential assertion of will, which certifies their identity and maintains their power. Concurrently, they exhibit a Holden Caulfield-like need to transgress. For them, humanity is viewed by means of a supremely myopic and self-absorbed lens through which streams a constant flow of self-serving misinformation, further reinforcing their false perspective on reality. All information that runs contrary to their interest is deemed fake and its source treated as an enemy. This type of nihilism had never, until recently, invaded our mainstream politics. But its here now for all to see, revealing itself in behavior that is alternatively outrageous, provocative, or transgressive. When effective, the result is a blurring of the lines between the offensive and the genuine.

We have to decide this year whether we agree that we are all in the same choir, as my dad insisted, or has the world really shifted that much? Will we perceive our election as a joining of our voices, once again, in one majestic expression of democracy or are we engaged in a fight to the finish?

What can we do? If we truly believe in the democratic process, we must require evidence for assertions made by all those who seek our vote. Claims by themselves should not be accepted as true, even if they cater to our prior beliefs. As good citizens, we must reject the lure of nihilism and its proponents while holding fast in protecting and promoting our values by participating robustly in the democratic process. We must demand a positive vision of the future from all the candidates, even those who share our own party affiliation. It is time to be inspired again, to reach higher, try harder and never give up in our efforts to achieve and maintain the true promise of America.

Perhaps John Lewis put in best when, in his final words, he wrote, So I say to you, walk with the wind, brothers and sisters, and let the spirit of peace and the power of everlasting love be your guide.

The choice is ours, my friends.

View original post here:

Walking with the Wind - TAPinto.net

How to watch the Joker movie in the UK – ExaminerLive

The Oscar-winning film Joker is heading to UK streaming services for the first time this month.

The Joaquin Phoenix fronted film will arrive to NowTV on Friday, August 7 via the Cinema Pass.

Viewers can sign up to the pass for a seven-day free trial at nowtv.com. Then you can cancel it before your free trial is up or continue it and pay 11.99 per month.

Based on DC Comics characters the film is set in in 1981, it follows Arthur Fleck, a failed stand-up comedian whose descent into insanity and nihilism inspires a violent counter-cultural revolution against the wealthy in a decaying Gotham City.

The film also features Robert De Niro, Zazie Beetz and Frances Conroy and was nominated for 11 Academy Awards winning two, including Best Actor for Phoenix.

Upon its release the film received polarising reviews with praise for Phoenix and the film's score, while some criticised the violence in the film and portrayal of mental illness.

The NowTV Cinema Pass is also home to big hits Spider-Man: Far From Home, Detective Pikachu, Rocketman, Toy Story 4 and The Lion King.

To find out more and to sign up go to NowTV website here.

Follow this link:

How to watch the Joker movie in the UK - ExaminerLive